- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.10 Promissory Note Dated July 6, 2021 with Church & Keeler, Inc.
- 10.11 Promissory Note Dated July 6, 2021 with Draper, Inc.
- 10.12 Promissory Note Dated July 6, 2021 with Happy David Walters
- 10.13 Promissory Note Dated July 9, 2021 with Carriage House Capital, Inc.
- 10.14 Promissory Note Dated July 22, 2021 with John Walters Nick, JR.
- 10.15 Promissory Note Dated July 22, 2021 with Gary Goodman
- 10.16 Promissory Note Dated July 26, 2021 with Stefan Galluppi
- 10.17 Promissory Note Dated August 4, 2021 with Justin Schreiber
- 10.18 Promissory Note Dated August 6, 2021 with Alexander Limited
- 10.19 Promissory Note Dated August 12, 2021 with Aliunde Limited
- 10.20 Promissory Note Dated September 28, 2021 with Neil Reithinger
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Exhibit 32.2
PEAK PHARMACEUTICALS, INC.
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report on Form 10-K of Peak Pharmaceuticals, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
By: | /s/ Neil Reithinger | |
Neil Reithinger | ||
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||
Date: December 19, 2022 |